27 April 2026
Australia uniquely has an approved testosterone cream for postmenopausal women with low sexual desire causing distress, following careful assessment. The evidence supports transdermal dosing for hypoactive sexual desire disorder, with monitoring to stay in the female physiological range and minimise side effects; it isn’t recommended for mood, cognition, or energy outside this indication.
